CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Framework (Products)
Duration
16 month
Value
£10M
Sector
HEALTH
Published
21 Jan 2025
Delivery
01 Feb 2025 to 31 May 2026
Deadline
18 Nov 2024 13:00

Concepts

Location

Geochart for 1 buyers and 6 suppliers

1 buyer

6 suppliers

Description

Project title: NHS National Framework for Transition products commencing 1 February 2025 Offer reference number: CM/TNS/24/5713 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months) Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months) Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Award Detail

1 Sun Pharma (Uxbridge)
  • Value: £9,867,000
2 Thornton & Ross (Huddersfield)
  • Value: £9,867,000
3 Drreddys Laboratories (Cambridge)
  • Value: £9,867,000
4 Zentiva Pharma (London)
  • Value: £9,867,000
5 Biocon (London)
  • Value: £9,867,000
6 Baxter Healthcare (Thetford)
  • Value: £9,867,000

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

Document No. 09 - Participating Authorities - CM_TNS_24_5713 Document No. 09 - Participating Authorities - CM_TNS_24_5713.xls Document No. 03 - Framework Agreement and Terms and Conditions CM-TNS-24-5713 Document No. 03 - Framework Agreement and Terms and Conditions CM-TNS-24-5713.docx Transparency Documents - CM_TNS_24_5713_01 Transparency Documents - CM_TNS_24_5713_01.pdf Parties Appointed to the Framework Agreement - CM-TNS-24-5713 Parties Appointed to the Framework Agreement - CM-TNS-24-5713.docx FTS 2024S 000-031160 - CM-TNS-24-5713 - Opportunity Notice FTS 2024S 000-031160 - CM-TNS-24-5713 - Opportunity Notice.pdf

Reference

Domains